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Open access under the ElWhey protein hydrolysate (WPH) is capable of increasing muscle glycogen reserves and of concentrating
the glucose transporter in the plasma membrane (PM). The objective of this study was to determine
which WPH components could modulate translocation of the glucose transporter GLUT-4 to the PM of
animal skeletal muscle. Forty-nine animals were divided into 7 groups (n = 7) and received by oral gavage
30% glucose plus 0.55 g/kg body mass of the following WPH components: (a) control; (b) WPH; (c) L-iso-
leucine; (d) L-leucine; (e) L-leucine plus L-isoleucine; (f) L-isoleucyl-L-leucine dipeptide; (g) L-leucyl-L-iso-
leucine dipeptide. After receiving these solutions, the animals were sacriﬁced and the GLUT-4 analysed
by western blot. Additionally, glycogen, glycaemia, insulin and free amino acids were also determined
by standard methods. Of the WPH components tested, the amino acid L-isoleucine and the peptide L-leu-
cyl-L-isoleucine showed greater efﬁciency in translocating GLUT-4 to the PM and of increasing glucose
capture by skeletal muscle.
 2013 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Whey protein (WP) represents almost 20% of the total protein in
bovine milk and has been recognised for its high nutritional qual-
ity, fast absorption and as a rich source of branched-chain amino
acids (BCAAs) (Hulmi, Lockwood, & Stout, 2010). Some properties
associated with the whey proteins, especially in their hydrolysed
form, have been the subject of some investigations; properties
such as the improved physical resistance of rats subjected to phys-
ical exhaustion (Pimenta, Abecia-Soria, Auler, & Amaya-Farfan,
2006), a reduction in muscle injury enzyme indicators (LDH, CK)
in soccer players during competition (Lollo, Amaya-Farfan, & Carv-
alho-Silva, 2011), contribution to protection against stress (de
Moura, Lollo, Morato, Carneiro, & Amaya-Farfan, 2013), an increase
in muscle fatty acids for use as an energy source during exercise
(Morifuji, Sakai, Sanbongi, & Sugiura, 2005a) and the capacity to re-
cover the glycogen levels in the liver and skeletal muscle after
exercise (Faria, Nery-Diez, Lollo, Amaya-Farfan, & Ferreira, 2012;inase; Akt, protein kinase B;
inotransferase; CK, creatine
e dehydrogenase; p85, PI 3
ic acid; WPH, whey protein
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sevier OA license.Morifuji, Kanda, Koga, Kawanaka, & Higuchi, 2010; Morifuji, Sakai,
Sanbongi, & Sugiura, 2005b; Pimenta et al., 2006).
Muscle glycogen synthesis is limited by the availability of glu-
cose, and in skeletal muscle glucose transport occurs mainly via
the glucose transport carrier proteins (GLUTs). GLUT-4 is the major
glucose transporter isoform expressed in skeletal muscle, and thus
the rate of muscle glucose transport is determined by the GLUT-4
concentration in the cell membrane, in response to insulin and/or
muscle contraction (Jentjens & Jeukendrup, 2003; MacLean, Zheng,
& Dohm, 2000).
Previous studies showed that whey protein hydrolysate (WPH)
and whey protein peptides containing BCAAs were capable of
increasing glucose and glycogen synthesis in rat muscles (Morifuji,
Koga, Kawanaka, & Higuchi, 2009; Pimenta et al., 2006). However
the glucose transporter expression was not analysed in these stud-
ies and our previous results suggested that WPH stimulated the
translocation of GLUT-4 to the cell membrane (data not shown).
Of the WPH components that could contribute to this effect, the
following stand out: (1) BCAAs – the amino acids L-leucine and L-
isoleucine improved glucose uptake in skeletal muscles, both
in vitro and in vivo (Doi et al., 2005; Nishitani, Takehana, Fujitani,
& Sonaka, 2005). (2) Dipeptides composed of BCAAs – Morifuji
et al. (2009) showed that the peptide L-isoleucyl-L-leucine, identi-
ﬁed as the main BCAA-containing amino acid in WPH, stimulated
glucose uptake and glycogen synthesis in vitro.
Based on the evidence that the consumption of whey protein
hydrolysate increased muscle glycogen reserves (Faria et al.,
854 P.N. Morato et al. / Food Chemistry 139 (2013) 853–8592012; Morifuji et al., 2005b, 2010; Pimenta et al., 2006), the objec-
tive of the present study was to identify which whey protein
hydrolysate components could have a relevant role in glucose cap-
ture. Thus the branched-chain amino acids L-leucine and L-isoleu-
cine and the peptides made up of these two amino acids, were
tested in vivo, since it was already shown that both the BCAAs
(Doi, Yamaoka, Fukunaga, & Nakayama, 2003; Doi et al., 2005)
and the peptides derived from them (Morifuji et al., 2009) could in-
crease cellular glucose capture in vitro. This was the ﬁrst study that
analysed a group of WPH components in vivo, considering their
passage through gastrointestinal digestion.2. Material and methods
2.1. Animals
Forty-nine male Wistar rats (21 days old) reared in the Multi-
disciplinary Centre for Biological Research, University of Campinas,
SP, Brazil, were housed (22 C, 55% RH, inverted 12-hlight cycle)
in individual growth cages, with access to commercial feed (Labina,
Purina, Brazil) and water ad libitum. The proximal composition of
the commercial feed (dry basis): 23.4% protein, 5.5% lipids, 10.2%
moisture, 8.6% ash. All experimental procedures were approved
by the Ethics Committee on Animal Experimentation (CEEA-UNI-
CAMP, protocol 2376-1/2011).2.2. Experimental procedures
When the animals reached 245 ± 14.8 g of body mass, they
were submitted to a glycogen depletion protocol consisting of
the following 2 steps: (1) training on the treadmill, running for
60 min at 15 m/min (to deplete muscle glycogen); and (2) 16 h
fasting after exercising (to deplete hepatic glycogen). This proce-
dure allowed analyses with the animals homogeneously depleted
of glycogen and at a moment of great inﬂux of glucose into the
cells, 16 h after the exercise, when expression of the glucose trans-
porters was maximum (Kuo, Browning, & Ivy, 1999; Ren, Semenko-
vich, Gulve, Gao, & Holloszy, 1994). With the glycogen reserves
depleted, the animals received by oral gavage the following solu-
tions described in Fig. 1A, and thirty minutes after oral ingestion
of the solutions, were killed by decapitation and the blood and tis-
sue samples immediately collected for analysis (Fig. 1B).Fig. 1. (A) Experimental design: Forty-nine animals were divided into 7 groups (n = 7); ea
(glucose/control); WPH (whey protein hydrolysate); Ile: isoleucine; Leu: leucine; Leu
isoleucyl-L-leucine peptide; Pep Leu-Ile: L-leucyl-L-isoleucine peptide. (B) Experimental p
fasting, but 30 min before the sacriﬁce the rats received a solution with different com
mobilisation at moment of death.2.3. Preparation of the oral solutions
Each animal received 0.55 g/kg body mass of the amino acid/
peptide dissolved in a 30% glucose solution and the groups were
as follows: a) CHO: 30% glucose (control group); (b) WPH: whey
protein hydrolysate, with the amount of liquid corrected according
to the protein purity (78%) (c) L-isoleucine (d) L-leucine (e) a 50:50
mixture of the amino acids L-leucine plus L-isoleucine (f) L-isoleu-
cyl-L-leucine dipeptide (g) L-leucyl-L-isoleucine dipeptide
(Fig. 1A). The peptides (purity >98%) were acquired from BioBasic
(Markham, Ontario, Canada), the amino acids L-leucine and L-iso-
leucine, at least 99.7% pure, donated by Ajinomoto (Sao Paulo, Bra-
zil), and the WPH donated by Hilmar Ingredients (Hilmar, CA).
2.4. Biochemical parameters
Blood samples were collected in Vacutainers maintained at 4 C,
and centrifuged at 3000g (4 C, 12 min) to obtain the serum. To as-
sess the serum, the following determinations were carried out: uric
acid, urea, albumin, total proteins, aspartate aminotransferase
(AST), alanine aminotransferase (ALT), creatine kinase (CK), lactate
dehydrogenase (LDH), and glucose using a spectrophotometer (DU
640; Beckman-Coulter, Palo Alto, CA) and Laborlab kits (São Paulo,
Brazil). The serum insulin levels were measured using a rat/mouse
insulin ELISA (Millipore, Billerica, MA).
2.5. Determination of glycogen
The skeletal muscle and the myocardial and liver tissues were
collected for glycogen analysis. Tissue glycogen was isolated and
puriﬁed by precipitation with ethanol from a basic digestion, and
then quantiﬁed by the phenol–sulphuric acid method (Lo, Russell,
& Taylor, 1970). The absorbance was read in a spectrophotometer
(Beckman-Coulter DU 640) at 490 nm.
2.6. Western blot analysis
The total protein content of the skeletal muscle was determined
by the Lowry method (Lowry, Rosebrough, Farr, & Randall, 1951).
For immunoblotting, tissue homogenates were subjected to gel
electrophoresis using SDS–PAGE and transferred to a nitrocellulose
membrane. The blots were probed with the appropriate antibodiesch animal received 30% glucose plus 0.55 g/kg body mass of WPH components: CHO
+ Ile: 50:50 mixture of the amino acids L-leucine plus L-isoleucine; Pep Ile-leu: L-
rotocol: The rats were killed after the exercise-induced glycogen depletion state and
ponents from whey protein hydrolysate (WPH), so there was glucose transporter
P.N. Morato et al. / Food Chemistry 139 (2013) 853–859 855to assess the protein level of the GLUT-4 (Abcam, Cambridge, UK;
catalog number ab654 diluted 1:5000), Akt 1/2/3 (H-136) antibody
SC8312 (Santa Cruz Biotechnology, Santa Cruz, CA; diluted 1:1000),
p-AKT 1,2,3 Ser 473, antibody SC 7985-R (Santa Cruz Biotechnol-
ogy; diluted 1:1000), anti-PI 3-kinase p85, N-SH2 domain (catalog
number 06-496, Upstate Biotechnology, Lake Placid, NY, diluted
1:1000), AMPK alpha 1 + AMPK alpha 2 phospho S485 + S491 (Ab-
cam; catalog number ab39400 diluted 1:1000). To assess the levels
of these proteins in the muscle, the loading control was tubulin
(Abcam; catalogue number ab44928, diluted 1:1000).
The appropriate secondary antibody conjugated to peroxidase
and the BM chemiluminescence blotting system (Abcam), were
used for detection. The bands were visualised using a GE, Image-
Quant, model LAS 4000 instrument. Speciﬁc protein bands present
in the blots were quantiﬁed using the digital program ImageJ (v.
1.44 for Windows).
2.7. Amino acid composition of the muscle and free amino acids of the
plasma
The free amino acids were extracted from the plasma and mus-
cle with methanol and derivatised with phenylisothiocyanate
[Waters pico-tag for free amino acids (WAT0 10954 Ver4)], and
the PTH-derivatives chromatographed using a Luna C-18,
250  4.6 mm (00G-4252-EQ; Phenomenex, Torrance, CA) column
at 50 C and quantiﬁed by comparison with a standard. The free
amino acids were extracted in 80% ethanol and 0.1 M HCl using
methionine sulphone as the internal standard. The mixture was
sonicated for 10 min and further homogenised for 1 h, followed
by centrifugation at 8497g for 15 min. The supernatant was ﬁltered
through a 0.22-mm membrane; a 40-lL aliquot was derivatised as
above and 20 lL injected into the liquid chromatograph.
2.8. Statistical analysis
The data were analysed using the software SPSS (Statistical
Package for the Social Sciences, Chicago, IL), version 17.0. The re-
sults were tested for normality (Kolmogorov–Smirnov test) and
homogeneity using the tools available therein. For the parametric
data, multivariate analysis of variance (ANOVA) was used and the
means were compared (Duncan test). The level of signiﬁcance was
set at p < 0.05.3. Results
Of the WPH components tested, provided at the same mass, the
amino acid L-isoleucine increased translocation of GLUT-4 to the
PM (Fig. 2A) and reduced the blood glucose levels (Fig. 2G). The
phosphorylation of Akt at serine 473 (Fig. 2D) was increased
(p < 0.05) by the peptide L-leucyl-isoleucine, which also presented
higher levels of plasma insulin (Fig. 2F).
The glycogen levels were determined in liver, skeletal muscle
and heart (Fig. 2H–J). The glycogen concentration of the skeletal
muscle showed no difference between the groups (Fig. 2I). In the
heart, the glycogen levels were higher for the animals who re-
ceived the L-isoleucine (Fig. 2J) and in the liver, the lowest glycogen
levels were found for the group that received L-isoleucine (Fig. 2H).
The complete amino acid proﬁles of the plasma (Table 1) and
muscle (Table 2) were determined. Higher concentrations of the
amino acid L-isoleucine were detected in the plasma of the groups
that received this free amino acid andWPH. In the muscle, the con-
centration found for L-isoleucine was higher in the group that re-
ceived the free amino acid.
The following general health parameters were assessed: albu-
min, total proteins, AST, ALT, LDH, CK, uric acid and urea (Table 3).For the muscle damage indicators CK and LDH, no differences were
observed (p > 0.05) between the groups. In addition, serum albu-
min, urea and total proteins appeared to be unaltered in all the
groups. AST and ALT were assessed as hepatic health parameters.
In the groups that received the peptides and amino acids, no signif-
icant differences were found for the liver marker AST and lower
levels of ALT were found in the group that received the amino acid
mixture (Leu + Ile). WPH contained the highest levels of uric acid.4. Discussion
The objective of this research was to identify which WPH com-
ponents, provided at the same masses, could make a signiﬁcant
contribution to the entrance of glucose and glycogen synthesis,
as promoted by the in vivo ingestion of this protein and considering
the effect of the digestive process on the WPH components. Of the
WPH components tested, comparing mass by mass, it was shown
that the amino acid L-isoleucine signiﬁcantly (p < 0.05) increased
the translocation of GLUT-4 to the PM (Fig. 2A), this increase being
consistent with the low blood glucose levels found in this group
(p < 0.05) (Fig. 2G), since a greater concentration of GLUT-4 in
the PM favours glucose capture by the muscle, decreasing the ser-
um levels. In earlier studies, L-isoleucine had presented a hypogly-
caemic effect (Doi, Yamaoka, Nakayama, Sugahara, & Yoshizawa,
2007; Doi et al., 2003), and, amongst the BCAAs, had promoted
the greatest translocation of GLUT-4 in the skeletal muscle of rats
with liver cirrhosis (Nishitani et al., 2005). The standard diet used
in experimental animal nutrition research uses casein as the pro-
tein source, considering this protein as the reference (Reeves, Niel-
sen, & Fahey, 1993). The composition of WPH (Table 4) shows
about 50% more L-isoleucine compared to casein, suggesting that
this amino acid could be contributing to the effects of this protein
in glucose transport into the skeletal muscle. Table 4 also shows
the amino acid composition of the commercial feed.
The amount of GLUT-4 in the PM is a primary factor in deter-
mining the maximal rate of glucose transport into the skeletal
muscle. Under normal resting conditions, most of the GLUT-4 mol-
ecules can be found in the membrane vesicles inside the muscle
cell. Insulin signalisation is amongst the factors most inﬂuencing
GLUT-4 translocation to the PM (Dohm, 2002), which, by way of
proteins such as AKT, p85, unleashes a cascade of signalising
events, culminating in the translocation of GLUT-4. Previous re-
sults showed that WPH had the ability to increase the insulin re-
sponse, although the exact mechanism behind this effect has yet
to be elucidated. The change in circulating amino acids has been
proposed as the primary regulator (Power, Hallihan, & Jakeman,
2009). However, the insulin levels were low in the group that re-
ceived L-isoleucine (Fig. 2F) although the translocation of GLUT-4
was high; thus in this case it seems that the translocation was
independent of insulin. The group showing the highest insulin con-
centrations was the group that received the peptide L-leucyl-iso-
leucine, which corresponds to 16% of the total amount of
dipeptides formed from the BCAAs present in WPH, and comes
from b-lactoglobulin, one of the WPH fractions (Morifuji et al.,
2009).
The higher insulin levels in the L-leucyl-isoleucine group were
consistent with a greater activation of Akt, phosphorylated on
the serine 473 residue (Fig. 2D – p-Akt), this protein being phos-
phorylated by insulin signalisation (Wang et al., 1999). On the
other hand the group that received L-isoleucine showed the lowest
p-Akt levels (Ser 473), coherent with the low plasma insulin con-
centrations, and reinforces evidence that L-isoleucine is capable
of translocating GLUT-4 without insulin signalisation, as described
by Nishitani et al. (2005). The present ﬁndings also agree with a
previously reported improvement in glucose tolerance in rats
Fig. 2. The effect (means and standard errors) of administering oral solutions (0.55 g/kg of body mass) dissolved in 30% glucose after glycogen depletion in Wistar rats: CHO
(glucose/control); WPH (whey protein hydrolysate); Ile: isoleucine; Leu: leucine; Leu + Ile: 50:50 mixture of the amino acids L-leucine plus L-isoleucine; Pep Ile-leu: L-
isoleucyl-L-leucine peptide; Pep Leu-Ile: L-leucyl-L-isoleucine peptide. The expression of the following proteins was determined by immunoblot: (A) Glucose transporter 4
(GLUT-4); (B) p85/tubulin; (C) Akt/tubulin (D) Akt phosphorylate (Ser 473)/tubulin (E) AMPK/tubulin in the skeletal muscle; and in addition for insulin (F) and glucose (G) in
the serum; and for glycogen in the: (H) liver; (I) skeletal muscle and (J) heart. Different superscript lower case letters indicate signiﬁcant differences between the groups (n = 7
per group). ANOVA was used and the means compared (Duncan test), adopting the value of p < 0.05 as the criterion for statistical signiﬁcance.
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Table 1
Mean and standard error of the mean (SE) of amino acids concentrations in plasma (lmol/L).
CHO WPH Ile Leu Leu + Ile Ile-Leu Leu-Ile
Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE
Aspartic acid 42.8a 7.0 36.9abc 0.6 27.9c 0.2 44.2a 2.0 28.7c 0.6 38.5ab 1.8 29.6bc 0.2
Glutamic acid 15.0b 0.4 18.5ab 0.6 20.7a 2.2 17.4ab 0.4 15.4b 0.7 15.4b 0.6 20.9a 1.7
Hydroxyproline 41.6c 1.1 53.4ab 6.3 59.1a 5.3 48.2abc 1.5 43.4bc 2.9 40.5c 1.0 50.9abc 2.0
Asparagine 83.5b 3.2 117.7a 13.1 122.4a 6.1 80.8b 0.0 77.0b 2.6 86.7b 1.3 84.4b 1.4
Serine 305.4b 11.8 373.0a 37.8 395.1a 3.4 270.3b 2.8 286.5b 1.9 304.7b 2.1 315.3b 5.2
Glutamine 438.4b 14.0 536.9a 43.9 554.6a 25.3 410.4b 20.2 425.5b 3.1 468.2b 16.7 408.7b 8.8
Glycine 180.1b 7.4 201.9a 10.3 208.4a 3.8 147.1a 1.0 162.8a 3.8 202.4a 17.6 177.2a 0.1
Histidine 41.2ab 1.4 44.5a 2.9 49.0a 4.7 30.4c 2.0 35.4bc 0.1 41.4ab 3.1 34.9bc 0.0
Taurine 81.2b 15.1 122.4a 14.6 133.8a 17.4 131.6a 10.6 105.3ab 2.8 145.4a 12.7 112.0ab 2.3
Arginine 98.9bc 2.9 112.1ab 7.9 110.6ab 11.0 116.2ab 9.3 81.1c 2.8 126.2a 8.9 85.5c 4.1
Alanine 258.9b 2.0 331.4a 18.4 302.6a 15.7 217.1b 0.1 252.6b 13.1 218.9b 1.9 242.6b 19.7
Threonine 466.6c 18.2 561.4bc 31.7 511.7bc 8.2 738.5a 31.5 436.6c 1.7 516.3bc 25.7 616.9ab 105.2
Proline 191.4b 9.2 245.7a 10.9 247.5a 29.4 215.7ab 0.9 215.1ab 1.4 218.4ab 1.6 243.3a 10.7
Tyrosine 41.1a 0.9 43.0a 1.9 41.3a 2.8 33.7b 1.0 31.7b 0.5 33.1b 2.3 31.5b 0.4
Valine 143.2b 12.2 195.4a 3.6 165.6b 10.0 56.6c 4.5 68.2c 5.9 66.3c 14.6 65.5c 0.4
Methionine 36.9b 6.3 35.0b 2.2 60.5a 0.1 17.2d 1.5 28.8bc 4.9 31.7bc 2.3 22.9cd 1.4
Isoleucine 92.7b 2.9 189.5a 5.3 191.6a 20.7 29.8c 0.8 92.8b 9.5 67.4b 2.0 71.6b 1.0
Leucine 49.4d 5.1 197.4a 6.0 129.2c 1.9 156.3b 3.0 49.7d 3.8 38.4d 0.9 40.0d 0.2
Phenylalanine 60.3ab 0.8 64.8a 3.1 53.5c 3.5 34.9c 1.1 36.5c 0.3 39.6c 3.9 34.0c 1.5
Tryptophan 142.8b 6.1 175.0a 15.7 127.8b 8.6 93.3c 7.7 96.1c 0.6 102.5c 4.0 90.1c 0.1
Ornithine 86.4a 4.0 74.4ab 10.4 59.5bc 9.2 41.4c 7.7 38.7c 4.3 47.6c 2.2 43.7c 3.6
Lysine 406.4 36.8 571.7 65.5 453.9 39.0 533.3 66.0 517.1 90.4 543.6 77.3 526.9 93.0
BCAAs 272.8 30.7 419.9 52.5 417.7 40.1 103.6 11.6 189.8 18.6 165.4 11.7 160.0 15.3
BCAAs: branched chain amino acids (valine, isoleucine, leucine). Alanine and Isoleucine are in bold type. The effect of administering oral solutions (0.55 g/kg) of body weight
dissolved in 30% glucose CHO: (glucose/control); WPH: whey protein hydrolysate; Ile: isoleucine; Leu: leucine; Leu + Ile: 50:50 mixture of the amino acids L-leucine plus L-
isoleucine; Ile-Leu: L-isoleucyl-L-leucine peptide; Leu-Ile: L-leucyl-L-isoleucine peptide. Different superscript lowercase letters indicate signiﬁcant differences between the
groups (n = 7 per group). ANOVA was used and means were compared (Duncan test), adopting the value of p < 0.05 as a criterion for statistical signiﬁcance.
Table 2
Mean and standard error of the mean (SE) of amino acids concentrations in skeletal muscle (lmol/kg).
CHO WPH Ile Leu Leu + Ile Ile-Leu Leu-Ile
Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE
Aspartic acid 27.2bc 3.6 19.1c 0.4 25.4bc 5.3 34.0ab 5.1 43.5a 4.0 28.2bc 0.0 27.9bc 1.0
Glutamic acid 963.4b 23.6 1041.2b 116.2 1721.4a 31.4 1467.0a 224.2 1725.1a 106.8 1078.7b 30.7 1484.5a 94.9
Hydroxyproline 349.1de 90.7 191.6e 15.0 412.9cd 111.6 614.8ab 17.9 666.3a 11.1 475.9bcd 11.5 552.3abc 30.5
Asparagine 273.1ab 88.0 384.5a 3.6 299.6ab 89.3 133.9b 26.5 139.6b 15.0 255.1ab 94.2 100.2b 0.2
Serine 171.5b 30.1 147.6b 0.0 248.9a 0.0 253.5a 37.2 265.1a 21.0 162.0b 12.4 208.1ab 11.2
Glutamine 5517.0ab 684.4 3749.3bc 434.7 2799.1c 113.9 3267.8c 1298.6 848.2d 58.0 5318.2ab 267.3 6504.7a 189.7
Glycine 447.0ab 93.2 277.7b 27.5 402.8b 81.5 628.4a 75.8 619.0a 17.0 392.5b 39.1 456.7ab 40.7
Histidine 416.2ab 91.0 259.0b 12.7 411.1ab 119.2 333.0b 42.4 571.3a 35.4 417.0ab 48.7 404.0ab 20.1
Taurine 1804.2ab 307.5 1115.7b 43.9 2165.4a 684.6 2525.4a 268.1 1897.3ab 18.5 1796.7ab 40.9 1947.0ab 85.9
Arginine 1913.5ab 276.0 1276.2b 4.3 2150.6ab 656.6 2611.6a 241.9 2930.2a 399.4 2155.0ab 94.9 2033.6ab 126.8
Alanine 253.6bc 52.2 155.9c 9.8 248.5bc 71.6 347.8ab 53.6 394.7a 39.5 255.3bc 15.7 233.4bc 7.4
Threonine 509.2b 38.9 703.3a 16.3 234.8cd 72.1 273.5c 87.8 108.8d 7.9 89.0d 2.2 701.4a 6.2
Proline 782.6a 34.6 386.5b 126.0 590.0ab 145.6 321.4b 128.5 739.2a 29.6 605.0ab 26.2 533.6ab 28.8
Tyrosine 21.0abc 3.2 10.1d 2.1 19.1bcd 2.5 27.6ab 4.2 30.7a 6.0 21.3abc 1.3 14.4cd 0.8
Valine 291.8ab 39.2 151.8b 45.3 328.7ab 88.4 297.2ab 64.5 400.8a 89.5 271.5ab 50.9 153.7b 8.3
Methionine 14.5ab 3.5 18.2ab 2.8 12.6ab 3.2 22.2a 5.3 21.4ab 5.4 14.2ab 1.0 9.7b 1.0
Isoleucine 137.8bc 22.9 123.0bc 13.8 255.8a 22.9 161.2bc 21.1 168.8b 28.4 121.3bc 16.0 100.3c 8.3
Leucine 203.8d 19.0 163.3d 5.6 270.6c 22.9 505.0a 31.2 387.6b 0.0 513.3a 0.0 470.9a 4.1
Phenylalanine 14.6 1.0 14.5 1.3 14.8 1.1 21.0 4.7 21.2 5.2 15.1 1.2 12.8 0.0
Tryptophan 62.4ab 4.4 66.7ab 12.7 50.5ab 11.0 85.0a 2.6 68.1ab 13.4 62.0ab 13.2 43.8b 3.9
Ornithine 51.9 11.6 90.3 23.7 53.2 17.1 42.4 25.7 37.5 5.9 46.9 7.0 45.0 0.3
Lysine 1728.5ab 504.6 2428.3a 812.1 1341.7ab 296.1 1837.4ab 327.4 1892.4ab 227.8 1099.3ab 75.8 948.5b 9.3
BCAAs 633.4 44.6 438.1 12.0 855.1 22.2 963.4 100.0 957.2 75.2 906.1 114.2 724.9 115.7
BCAAs: branched chain amino acids (valine, isoleucine, leucine). Isoleucine and leucine are in bold type. The effect of administering oral solutions (0.55 g/kg of body weight)
dissolved in 30% glucose CHO: (glucose/control); WPH: whey protein hydrolysate; Ile: isoleucine; Leu: leucine; Leu + Ile: 50:50 mixture of the amino acids L-leucine plus L-
isoleucine; Ile-Leu: L-isoleucyl-L-leucine peptide; Leu-Ile: L-leucyl-L-isoleucine peptide. Different superscript lowercase letters indicate signiﬁcant differences between the
groups (n = 7 per group). ANOVA was used and means were compared (Duncan test), adopting the value of p < 0.05 as a criterion for statistical signiﬁcance.
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cine, despite the lack of increase in Akt/PKB phosphorylation (Ber-
nard et al., 2011). AMPK has been indicated as a protein capable of
inducing muscle glucose intake (Musi & Goodyear, 2003). The pres-
ent results show greater activation of AMPK in the group that re-
ceived the L-leucyl-isoleucine peptide, which presented elevated
translocation of GLUT-4, similar to that found for WPH (Fig. 2E).
On the other hand the protein PI3-kinase (p85), involved in insulinsignalisation, was apparently unaffected by any of the WPH com-
ponents analysed in this study (Fig. 2B). Bernard et al. (2012) found
that a mixture of amino acids, composed mainly of L-isoleucine, did
not activate the PI3-kinase in rat muscle.
In the present study, there was no difference between the
groups, with respect to the glycogen content of the skeletal muscle.
However, the experimental design of the study was focused on the
moment of greater mobilisation of the glucose transporters, which
Table 3
Mean and standard error of the mean (SE) of biochemical blood parameters.
Albumina TPROTb ASTc ALTd LDHe CKf Ureag Uric acidh
Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE
CHOi 3.55 0.20 4.92 0.38 40.14b 5.48 20.20a 2.22 837.61 95.38 1409.43 286.51 31.34 2.00 1.76ª 0.30
WPHj 3.29 0.16 4.59 0.30 47.71ab 2.37 19.41ab 1.48 751.26 68.94 1287.55 210.63 44.36 5.80 1.94ª 0.26
Ilek 3.29 0.09 4.89 0.21 48.37ab 4.38 16.26ab 1.48 686.50 39.66 1097.32 135.18 32.14 3.46 1.30ab 0.12
Leul 3.32 0.09 5.08 0.38 48.45ab 3.83 17.14ab 1.17 711.01 76.58 1207.05 207.95 37.72 6.59 1.19b 0.06
Leu + Ilem 3.26 0.07 4.78 0.30 42.13ab 2.62 14.60b 0.95 644.68 74.82 1145.89 180.32 35.71 2.74 1.45ab 0.22
Ile-Leun 3.06 0.32 4.98 0.63 52.41ab 6.37 15.58ab 1.58 689.20 61.82 1313.64 202.42 35.18 3.27 1.39ab 0.24
Leu-Ileo 3.37 0.12 5.44 0.39 54.53ab 2.55 16.03ab 0.69 672.33 53.29 1199.41 192.36 34.99 4.36 1.44ab 0.06
Different superscript lowercase letters indicate signiﬁcant differences between the groups (n = 7 per group). ANOVA was used and the means compared (Duncan test),
adopting the value of p < 0.05 as the criterion for statistical signiﬁcance.
a g/dL.
b TPROT: total proteins (mg/dL).
c AST: aspartate aminotransferase (U/L).
d ALT: alanine aminotransferase (U/L).
e LDH: lactate dehydrogenase (U/L).
f CK: creatine kinase (U/L).
g mg/dL.
h mg/dL. The effect of administering oral solutions (0.55 g/kg of body weight) dissolved in 30% glucose, 30 min before death.
i CHO: (glucose/control).
j WPH: whey protein hydrolysate.
k Ile: isoleucine.
l Leu: leucine.
m Leu + Ile: 50:50 mixture of the amino acids L-leucine plus L-isoleucine.
n Ile-Leu: L-isoleucyl-L-leucine peptide.
o Leu-Ile: L-leucyl-L-isoleucine peptide.
Table 4
Amino acid proﬁle of the protein sources (g/100 g of protein) and commercial feed (g/
100 g), dry basis.
Amino acid CASa WPHb Commercial feedc
Asparagine 5.96 11.16 1.83
Glutamate 19.00 17.99 4.01
Serine 4.68 5.04 1.09
Glycine 1.39 1.75 0.87
Histidine 2.12 1.27 0.34
Arginine 3.03 2.31 1.33
Threonine 3.56 7.40 0.63
Alanine 2.30 4.89 0.92
Proline 8.85 5.68 1.23
Tyrosine 4.57 2.78 0.83
Methionine 2.32 2.52 0.17
Cystine 0.16 1.60 0.13
Isoleucine 4.51 6.97 0.63
Leucine 7.62 10.15 1.66
Valine 5.36 5.81 0.92
Phenylalanine 3.89 2.78 0.99
Lysine 6.62 9.48 1.44
BCAAs 17.49 22.93 3.21
a CAS: casein.
b WPH: whey protein hydrolysate.
c Commercial feed (Labina, Purina, Brazil).
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recover according to the protocol used, only 30 min after ingestion
of the different nutrients (Fig. 2I), since glycogen recovery can take
up to 24 h, depending on the extent of depletion and the diet con-
sumed (Jentjens & Jeukendrup, 2003). On the other hand, the gly-
cogen levels were higher in the heart muscle of the animals who
received the L-isoleucine, and lower in those who received L-leu-
cine (Fig. 2J). The heart is a vital organ and can respond differently
to catabolic conditions, such as fasting and exercise, preserving en-
ergy substrates such as glycogen (Faria et al., 2012). In the liver, the
lowest glycogen levels were found for the group that received L-
isoleucine (Fig. 2H). This fact is consistent with the indications of
Doi et al. (2007), and Yoshizawa (2012), who indicated that in
the liver L-isoleucine inhibited gluconeogenesis, decreasing the
activities of the glycogenic enzymes and the production of glucose,mechanisms associated with the hypoglycaemic effect of L-
isoleucine.
The amino acid proﬁles of the plasma and muscle were also
determined. Of the results obtained, the amino acid alanine, a glu-
cogenic substrate, showed higher levels in the plasma of the
groups that received L-isoleucine and WPH. Doi et al. (2007) found
elevated levels of alanine in the plasma of rats that received L-iso-
leucine. The authors suggested a competitive effect between L-iso-
leucine and L-alanine for hepatic transport via the neutral amino
acid transporter, increasing the levels of L-alanine in the plasma
and decreasing the synthesis of glucose in the liver. The concentra-
tions of the amino acid L-isoleucine were higher in the plasma of
the groups that received this free amino acid and WPH, consistent
with other results found in this study, which suggested that this
amino acid was present in large amounts in WPH and could con-
tribute to the effects of the protein in capturing glucose. In the
muscle, the L-isoleucine concentration was higher in the group that
received the free amino acid.
With respect to the blood parameters, the muscle damage
markers CK and LDH (Brancaccio, Maffulli, Buonauro, & Limongelli,
2008) did not vary between the groups. In addition, no signiﬁcant
alterations were found in serum albumin, urea or the total pro-
teins. In the groups that received the peptides and amino acids,
no signiﬁcant differences were found for the liver marker AST,
and lower levels of ALT were found in the group that received
the amino acid mixture (Leu + Ile). Uric acid is an abundant and
important serum antioxidant (Waring et al., 2003). The results
indicated that the WPH provided the antioxidant protection of uric
acid.5. Conclusions
When considering their passage through the gastric intestine
during digestion, the data obtained in this study showed that of
the whey protein hydrolysate components tested in vivo, provided
at the same masses, it appears that the peptide L-leucyl-L-isoleu-
cine and the amino acid L-isoleucine were the components most
contributing to the increase in translocation of the major glucose
transporter, GLUT-4, and the entrance of glucose into the skeletal
P.N. Morato et al. / Food Chemistry 139 (2013) 853–859 859muscle. This could explain, at least in part, the high concentration
of GLUT-4 found in the plasmatic membrane, the consequently
greater inﬂux of glucose into the cell and the concentrations of gly-
cogen in the animals fed on whey protein hydrolysate. In addition,
it must be highlighted that in insulin resistance and in type 2 dia-
betes, the plasma glucose level is high, due to a lack of glucose
transporters in the plasmatic membrane, a problem which could
be overcome by a greater presence of GLUT-4 in the plasmatic
membrane. Thus new studies should be carried out considering
the potential of whey protein hydrolysate and its components in
the treatment of insulin resistance, so as to take greater advantage
of the functional role of whey protein hydrolysate.Acknowledgements
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